Correction to: Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells

Lufeng Zheng; Qianqian Guo; Chenxi Xiang; Shijia Liu; Yuzhang Jiang; Lanlan Gao; Haiwei Ni; Ting Wang; Qiong Zhao; Hai Liu; Yingying Xing; Yaohui Wang; Xiaoman Li; Tao Xi

doi:10.1186/s13045-019-0809-3

Journal of Hematology & Oncology (Oct 2019)

Correction to: Transcriptional factor six2 promotes the competitive endogenous RNA network between CYP4Z1 and pseudogene CYP4Z2P responsible for maintaining the stemness of breast cancer cells

Lufeng Zheng,
Qianqian Guo,
Chenxi Xiang,
Shijia Liu,
Yuzhang Jiang,
Lanlan Gao,
Haiwei Ni,
Ting Wang,
Qiong Zhao,
Hai Liu,
Yingying Xing,
Yaohui Wang,
Xiaoman Li,
Tao Xi

Affiliations

Lufeng Zheng: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University
Qianqian Guo: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University
Chenxi Xiang: Department of Pathology, The Affiliated Hospital of Xuzhou Medical University
Shijia Liu: Department of Pharmacy, Jiangsu Province Hospital of TCM
Yuzhang Jiang: Department of Clinical Laboratory, Huai An First People’s Hospital
Lanlan Gao: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University
Haiwei Ni: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University
Ting Wang: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University
Qiong Zhao: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University
Hai Liu: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University
Yingying Xing: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University
Yaohui Wang: Department of Pathology, Jiangsu Province Hospital of TCM
Xiaoman Li: Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine
Tao Xi: Jiangsu Key Laboratory of Carcinogenesis and Intervention, School of Life Science and Technology, China Pharmaceutical University

DOI: https://doi.org/10.1186/s13045-019-0809-3
Journal volume & issue: Vol. 12, no. 1
pp. 1 – 2

Abstract

Read online

The original article [1] contained an error in Fig. 7c whereby the same flow image was accidentally misused for the second and fourth group.

Published in Journal of Hematology & Oncology

ISSN: 1756-8722 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs; Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jhoonline.biomedcentral.com/

About the journal